Journal Guide

Formerly the IMA Journal of Mathematics Applied in Medicine and Biology.Mathematical Medicine and Biology publishes original articles with a significant mathematical content addressing topics in medicine and biology. Papers exploiting modern developments in applied mathematics are particularly welcome. The biomedical relevance of mathematical models should be demonstrated clearly and validation by comparison against experiment is strongly encouraged.The journal welcomes contributions relevant to any area of the life sciences including: * biomechanics * biophysics * cell biology * developmental biology * ecology and the environment * epidemiology * immunology * infectious diseases * neuroscience * pharmacology * physiology * population biology.

The journal publishes timely, critical reviews of topics related to medicinal research, broadly defined, to which the authors have made significant contributions. Appropriate topics include, but are not limited to, the underlying pathophysiology of important diseases and disease vectors; therapeutic approaches to the treatment of various diseases; the properties of molecular targets for therapeutic agents; important new methodologies facilitating the search for therapies; genomics and proteomics; structure-activity correlations of drug series; the development of new imaging and diagnostic tools; drug metabolism; drug delivery; and chemical, pharmacological, pharmacokinetic, pharmacodynamic, and clinical characteristics of important drugs. Reviews are mainly solicited by the editors; however, voluntary contributions are also encouraged. In the latter case, potential authors are asked to contact the Editor-in-chief with an outline before beginning to write in order to avoid duplication of effort and to ensure suitability of the topic and the level of coverage.

The powerful emergence and global spread of antibiotic resistant microbial pathogens and resistance genes in the 1990s presents challenges to a wide range of disciplines - from the molecular biology of resistance mechanisms, virulence genes, and disease through molecular epidemiology all the way to drug design, infection control, and medical practice. This international journal provides a multidisciplinary forum for peer-reviewed original publications as well as topical reviews and special reports.

The scope of Mini-Reviews in Medicinal Chemistry will cover all areas of medicinal chemistry including developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, drug targets, and natural product research and structure-activity relationship studies.

Insights into the latest molecular diagnostic and pharmacogenomic techniques and their use in personalized medicine.

Monthly issues present original applications of biochemistry, biophysics, genetics, and molecular biology juxtaposed with innovative pharmacologic research to elucidate basic problems in pharmacology and toxicology, including areas such as molecular mechanisms involved in drug receptor-effective coupling, xenobiotic metabolism, and antibiotic and anticancer drug action.Molecular Pharmacology is archived in CLOCKSS.

Molecular Therapy is the leading journal for research in the areas of gene transfer, vector development and design, stem cell manipulation, development of gene-, peptide- and protein-, oligonucleotide- and cell-based therapeutics to correct genetic and acquired diseases, vaccine development, pre-clinical target validation, safety/efficacy studies, and clinical trials. Available in print and online, Molecular Therapy is dedicated to promoting the sciences in genetics, medicine and biotechnology. Publishing important peer-reviewed research and cutting-edge reviews and commentaries, the journal continues to attract the best material in the field. Molecular Therapy's 2009 impact factor is 6.239*.

Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. In addition to the highest-quality reviews and perspectives covering the entire field, each issue includes news stories that investigate the hottest topics in drug discovery, timely summaries of key primary research papers, and concise updates on the latest advances in fast-moving areas such as new drug approvals, patent law and emerging industry trends.Subjects covered * Target discovery * Rational drug design * Combinatorial and parallel synthesis * Medicinal chemistry * Key compound classes * Natural products * High-throughput screening * Novel therapeutic approaches to disease states * Microarrays * Bioinformatics and chemoinformatics * Absorption, distribution, metabolism and elimination (ADME) * Pharmacokinetics and pharmacodynamics * Pharmacology * Toxicology * Pharmacogenomics and toxicogenomics * Drug delivery * Biopharmaceuticals * Biotechnology * Vaccines * Clinical trial evaluation * Regulatory issues * Pharmacoeconomics.

Founded in 1873, Naunyn-Schmiedeberg's Archives of Pharmacology is edited on behalf of the German Society of Experimental and Clinical Pharmacology and Toxicology (DGPT), and the Sphingolipid Club. This monthly journal publishes invited reviews, original articles and short communications. Coverage focuses on new and significant information on drug action and toxicity of chemical compounds. Thus, its scope extends to all fields of experimental and clinical pharmacology as well as toxicology and includes studies in the fields of neuropharmacology and cardiovascular pharmacology as well as those describing drug actions at the cellular, biochemical and molecular levels. Short communications offer rapid publication of significant findings of current interest that represent a conceptual advance in the field.

Neuropharmacology publishes high quality, original research and review articles within the discipline of neuroscience, especially articles with a neuropharmacological component. However, papers within any area of neuroscience will be considered. The journal does not usually accept clinical research, although preclinical neuropharmacological studies in humans may be considered. The journal only considers submissions in which the chemical structures and compositions of experimental agents are readily available in the literature or disclosed by the authors in the submitted manuscript. Only in exceptional circumstances will natural products be considered, and then only if the preparation is well defined by scientific means. Neuropharmacology publishes articles of any length (original research and reviews).Neuropharmacology also publishes succinct topical reviews on subjects within its remit. These reviews (of between 3000 and 5000 words) are commissioned by the Editorial Team or arise after correspondence with potential authors. Unsolicited reviews will be considered, but authors are encouraged to contact the Editor-in-Chief ahead of time of their intention to submit a review and to indicate clearly how the review differs from, and adds to, recent published reviews on related topics. On the basis of the case made by authors, potential overlap with planned Neuropharmacology content, and discussions with the Editorial Team, the Editor-in-Chief will provide authors with a decision regarding their proposed review as quickly as possible.The scope of the journal is broad. It covers many disciplines and spans molecules (e.g., molecular biology, biochemistry) through systems (e.g., neurophysiology) to behaviour (e.g. cognition, psychopharmacology). The journal covers all aspects of neuroscience with an emphasis on neurotransmitters and their receptors, ion channels, signalling, psychcopharmacology and animal models of disease, such as investigations on the neurobiology of cognition, depression, schizophrenia, anxiety, epilepsy, ischaemia, neuroprotection, neurodegeneration, drugs of abuse and pain.The journal publishes occasional Special Issues (and will consider publishing Supplements). Each year Elsevier/Neuropharmacology organise a satellite symposium to the Meeting of the Society for Neuroscience. The journal publishes a Special Issue to accompany each meeting. Please see http://www.neuropharmacology-conference.elsevier.com/ for details of this year's meeting and accompanying Special Issue.US National Institutes of Health (NIH) voluntary posting ("Public Access") policyNeuropharmacology and Elsevier facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authors

Neuropsychopharmacology is an international scientific journal and the official publication of the American College of Neuropsychopharmacology (ACNP). This journal focuses upon clinical and basic science contributions that advance our understanding of the brain and behaviour, especially as related to the molecular, cellular, physiological and psychological properties of agents acting within the central nervous system and the identification of the new molecular targets for the development of the next generation of drugs. While original reports are preferred, mini-reviews and perspectives are invited by the editorial office. In view of the interdisciplinary nature of the field, particular emphasis is placed on:* studies that advance the biological bases of normal and pathological behavior* the nature, etiology and pathophysiology of neuropsychiatric disorders* biologically relevant aspects of the epidemiology, diagnosis, and treatment of these disorders* and the basic mechanisms by which psychopharmacological agents exert their effect.

Neurotherapeutics® is the journal of the American Society for Experimental NeuroTherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders, written by international authorities.  The Journal also includes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field. Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues. Future Issue ThemesJanuary 2013 - Multiple Sclerosis
Guest Editor: Rohit Bakshi (BWH/Harvard)April 2013 - Mitochondrial Mechanisms in Neurologic Disease
Guest Editor: Andrea Gropman (Children’s National Medical Center) July 2013 - Protein Misfoldi

This journal is the official publication of the International Association for the Study of Pain and publishes original research on the nature, mechanisms and treatment of pain. The journal provides a forum for the dissemination of research in the basic and clinical sciences of multidisciplinary interest.Editor-in-Chief: Allan I. Basbaum Learn moreElectronic usageAn increasing number of readers access the journal online via ScienceDirect, one of the world's most advanced web delivery systems for scientific, technical and medical information.Average monthly article downloads for this journal: 80,097* Figure is an average based on full text articles downloaded monthly via ScienceDirect between July 2008 and June 2009.